12967_2019_1824_MOESM11_ESM.tif (298.5 kB)
MOESM11 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
figure
posted on 2019-03-04, 05:00 authored by Qian Song, Jun Shang, Zuyi Yang, Lanlin Zhang, Chufan Zhang, Jianing Chen, Xianghua WuAdditional file 11: Figure S9. The KaplanâMeier survival analysis of the signature for LUAD subgroup patients in GSE81089 dataset. Patients of high-risk exhibited poor prognosis in stage III cohort (Pâ<â0.05). There was no association of the risk score with patients of stage I cohort, stage II cohort, and stage IV cohort.
